To address the need of more rapid diagnosis of potential pathogens causing sepsis or septic shock in patients, Q-linea is developing a fully automated, high-throughput diagnostic platform, ASTrID. The system will perform both molecular pathogen identification and phenotypic antibiotic susceptibility testing, directly from whole blood, delivering ID after four hours and AST in an additional six.
After launch of the ASTrID sepsis assay other assays for infectious disease diagnostics will be placed on the system.
A pre-clinical study is currently performed in collaboration with the University Hospital of Örebro, Sweden. This study is one of several ongoing pre-clinical collaborations with Scandinavian hospitals.Read more »